Multicenter, randomized, double-blind, parallel clinical trial evaluating the efficacy and safety of safinamide versus rasagiline in fatigue associated with Parkinson's disease.
CLINICAL TRIAL WITH MEDICINES
Clinical trial information
- Promoter: L´HOSPITAL D RESEARCH INSTITUTE
- Phase: IV
- Execution start: 13/02/2024
- End of execution: 30/06/2025
- PI: FRANCISCO ESCAMILLA SEVILLA
